Department of Cardiology, Maastricht University Medical Center+ (MUMC+), Maastricht, The Netherlands.
Department of Research & Development, CIRO, Horn, The Netherlands.
ESC Heart Fail. 2022 Feb;9(1):614-626. doi: 10.1002/ehf2.13704. Epub 2021 Nov 18.
It is increasingly recognized that the presence of comorbidities substantially contributes to the disease burden in patients with heart failure (HF). Several reports have suggested that clustering of comorbidities can lead to improved characterization of the disease phenotypes, which may influence management of the individual patient. Therefore, we aimed to cluster patients with HF based on medical comorbidities and their treatment and, subsequently, compare the clinical characteristics between these clusters.
A total of 603 patients with HF entering an outpatient HF rehabilitation programme were included [median age 65 years (interquartile range 56-71), 57% ischaemic origin of cardiomyopathy, and left ventricular ejection fraction 35% (26-45)]. Exercise performance, daily life activities, disease-specific health status, coping styles, and personality traits were assessed. In addition, the presence of 12 clinically relevant comorbidities was recorded, based on targeted diagnostics combined with applicable pharmacotherapies. Self-organizing maps (SOMs; www.viscovery.net) were used to visualize clusters, generated by using a hybrid algorithm that applies the classical hierarchical cluster method of Ward on top of the SOM topology. Five clusters were identified: (1) a least comorbidities cluster; (2) a cachectic/implosive cluster; (3) a metabolic diabetes cluster; (4) a metabolic renal cluster; and (5) a psychologic cluster. Exercise performance, daily life activities, disease-specific health status, coping styles, personality traits, and number of comorbidities were significantly different between these clusters.
Distinct combinations of comorbidities could be identified in patients with HF. Therapy may be tailored based on these clusters as next step towards precision medicine. The effect of such an approach needs to be prospectively tested.
越来越多的人认识到合并症的存在大大增加了心力衰竭(HF)患者的疾病负担。有几项报告表明,合并症的聚类可以更好地描述疾病表型,这可能会影响对个体患者的治疗。因此,我们旨在根据合并症及其治疗方法对 HF 患者进行聚类,然后比较这些聚类之间的临床特征。
共纳入 603 例接受门诊 HF 康复计划的 HF 患者[中位数年龄 65 岁(四分位距 56-71),57%为缺血性心肌病,左心室射血分数 35%(26-45)]。评估了运动表现、日常生活活动、疾病特异性健康状况、应对方式和人格特质。此外,根据靶向诊断和适用的药物治疗记录了 12 种临床相关的合并症。使用自组织映射(SOM;www.viscovery.net)可视化聚类,该方法使用 Ward 经典层次聚类方法与 SOM 拓扑相结合的混合算法生成。确定了 5 个聚类:(1)合并症最少的聚类;(2)消瘦/内爆的聚类;(3)代谢性糖尿病聚类;(4)代谢性肾脏聚类;和(5)心理聚类。这些聚类之间的运动表现、日常生活活动、疾病特异性健康状况、应对方式、人格特质和合并症数量存在显著差异。
可以在 HF 患者中确定不同的合并症组合。作为迈向精准医学的下一步,可以根据这些聚类进行治疗。需要前瞻性测试这种方法的效果。